The Gujarat-based group has more than 130 USFDA approvals and has filed over 300 abbreviated new drug applications (ANDAs) since it commenc...

The Moraiya manufacturing plant had completed the USFDA audit from February 6th to 15th 2017 with Zero 483 observations, the company said.

From May 19’s closing of Rs 100.45, Videocon has lost 71.5% to close last week at Rs 28.55.

Buy Cadila Healthcare Ltd. at a price target of Rs 600. Edelweiss says Cadila's US business growth will be best-in-class at 48 per cent wit...

The USFDA has given its final approval to market mesalamine delayed-release tablets USP 1.2 g in the US market.

Zydus Cadila was the first to file an Abbreviated New Drug Application (ANDA) for the generic version of Lialda (mesalamine), the company s...

India's fifth largest drug maker by revenue, Zydus Cadila Group has settled a patent litigation with US-based Warner Chilcott Company LLC.

Cadila Healthcare along with Zydus Pharmaceuticals have entered into an agreement with Warner Chilcott Company to settle all outstanding pa...

US based Warner Chilcott Plc has moved court against Zydus Cadila's plan to produce a bowel inflammation drug Asocol.

The Rs 3,700-crore Zydus Group’s US subsidiary Zydus Pharmaceuticals USA has challenged the Irish company Shire Pharmaceuticals over its pa...

American consumer products major Procter & Gamble Company will be selling its global pharmaceuticals business to Ireland-based pharma entit...